On the basis of these data demonstrating the important function that IGF-I stimulation and cap-mediated protein translation have in the malignant potential of mesothelioma cells, these therapies could prove to be promising treatments for mesothelioma. This evidence concerns the gene IGF1 and mesothelioma.